Registration Opening Soon for BOS Events 2025!

Dates for BOS Events 2025 are confirmed as 11th and 12th June for BOS Basel 2025 and 25th and 26th November for BOS Manchester 2025. Please find further details outlining provisional floor plans and pricing options at the event links provided. Note that we plan to open for registrations on Monday 4th November at 09.00 GMT.

The focus of these events is partnerships in R&D outsourcing with the primary scope being development-stage CMC outsourcing of Small Molecules, Biologics and New Therapeutic Entities.

We continue to evaluate the opportunity for digital events and resources, please look out for an announcement soon on this. We look forward to welcoming you and your colleagues to BOS Events! Please contact the Bio2Business team for further details.

Follow us on LinkedIn to see our latest announcements


Featured Company (BOS Basel 2024)

Logo for Cencora PharmaLex
Cencora PharmaLex
PharmaLex is now part of Cencora, a leading global pharmaceutical solutions organization centered on improving lives around the world.

PharmaLex adds to Cencora’s expanding suite of pharma solutions and serves the pharma, biotech, and medtech industries. We guide clients from early strategic planning...
View profile

Featured Speaker (BOS Basel 2024)

photo of Dr Dr Rob Abbenhuis

Process Development and Commercialization of Highly Potent APIs

Dr Rob Abbenhuis, CHEM Division Manager, Ardena

ABSTRACT: Process development, commercialization and manufacturing of highly potent API’s presents significant challenges but it also represents a major opportunity for biotech companies looking to bring new treatments to patients. However, handling these HPAPI’s requires expertise, specific equipment and organizational and technical measures to ensure control of occupational exposure and to avoid cross-contamination to ensure operator safety as well as
patient safety.
This presentation aims to provide a comprehensive overview of the best
practices applied at Ardena, offering pharmaceutical... Click here to Read More